Mode and site of action of therapies targeting CGRP signaling

Mode and site of action of therapies targeting CGRP signaling

Abstract Targeting CGRP has proved to be efficacious, tolerable, and safe to treat migraine; however, many patients with migraine do not benefit from drugs that antagonize the CGRPergic system. Therefore, this review focuses on summarizing the general pharmacology of the different types of treatment...

Full description

Bibliographic Details
Main Authors: Alejandro Labastida-Ramírez, Edoardo Caronna, Cédric Gollion, Emily Stanyer, Austeja Dapkute, Diana Braniste, Hoda Naghshineh, Liga Meksa, Nino Chkhitunidze, Tamari Gudadze, Patricia Pozo-Rosich, Rami Burstein, Jan Hoffmann
Format: Article
Language:English
Published: BMC 2023-09-01
Series:The Journal of Headache and Pain
Subjects:
Amylin
Anti-CGRP
Calcitonin
Headache
Migraine
Trigeminal
Online Access:https://doi.org/10.1186/s10194-023-01644-8

Internet

https://doi.org/10.1186/s10194-023-01644-8

Similar Items